NASDAQ:PROF - Profound Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $27.00
  • Forecasted Upside: 138.52 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 1 Strong Buy Ratings
$11.32
▼ -0.23 (-1.99%)

This chart shows the closing price for PROF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Profound Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PROF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PROF

Analyst Price Target is $27.00
▲ +138.52% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Profound Medical in the last 3 months. The average price target is $27.00, with a high forecast of $32.00 and a low forecast of $21.00. The average price target represents a 138.52% upside from the last price of $11.32.

This chart shows the closing price for PROF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 investment analysts is to buy stock in Profound Medical. This rating has held steady since March 2020, when it changed from a Strong Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/5/2020
  • 1 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/3/2020
  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/2/2020
  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/2/2021
  • 1 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2021
  • 1 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/29/2021
  • 1 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2021
  • 1 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/27/2021

Latest Recommendations

  • 1 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/8/2021Raymond JamesLower Price TargetStrong-Buy$30.00 ➝ $28.00Low
10/27/2021Raymond JamesLower Price TargetStrong-Buy$36.00 ➝ $30.00Medium
9/30/2021Raymond JamesSet Price TargetStrong-Buy$36.00High
9/29/2021Raymond JamesBoost Price TargetStrong-Buy$46.00High
8/26/2021Raymond JamesSet Price TargetStrong-Buy$36.00Low
8/5/2021Raymond JamesSet Price TargetStrong-Buy$36.00Low
7/1/2021Raymond JamesSet Price TargetStrong-Buy$36.00Low
6/30/2021Raymond JamesBoost Price TargetStrong-Buy$44.50Low
6/21/2021Raymond JamesReiterated RatingStrong-Buy$36.00Low
5/13/2021Alliance Global PartnersLower Price TargetBuy$28.25 ➝ $21.00Low
5/10/2021Raymond JamesSet Price TargetStrong-Buy$36.00High
5/4/2021Raymond JamesBoost Price TargetStrong-Buy$34.00 ➝ $36.00Medium
3/29/2021Raymond JamesReiterated RatingStrong-Buy$34.00Low
3/10/2021Raymond JamesReiterated RatingStrong-Buy$34.00Low
3/4/2021Leede Jones GabReiterated RatingBuyMedium
1/25/2021Lake Street CapitalBoost Price Target$27.00 ➝ $32.00Medium
1/7/2021Alliance Global PartnersBoost Price TargetBuy$20.25 ➝ $28.25N/A
9/15/2020Jefferies Financial GroupInitiated CoverageBuyHigh
9/10/2020Lake Street CapitalInitiated CoverageBuy$22.00High
8/7/2020Alliance Global PartnersReiterated RatingBuy$15.00 ➝ $18.00High
7/31/2020Raymond JamesBoost Price TargetStrong-Buy$38.00 ➝ $43.00High
6/26/2020Raymond JamesBoost Price TargetStrong-Buy$35.00 ➝ $38.00Low
4/7/2020MackieDowngradeBuy ➝ HoldHigh
4/1/2020CowenInitiated CoverageOutperform$15.00Medium
1/27/2020Raymond JamesUpgradeOutperform ➝ Strong-BuyLow
11/8/2019Echelon Wealth PartnersReiterated RatingBuyLow
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.01 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/30/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 0 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 0 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Profound Medical logo
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The firm's platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.
Read More

Today's Range

Now: $11.32
Low: $11.10
High: $11.47

50 Day Range

MA: $13.56
Low: $11.30
High: $15.64

52 Week Range

Now: $11.32
Low: $11.10
High: $28.97

Volume

50,591 shs

Average Volume

71,221 shs

Market Capitalization

$235.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Frequently Asked Questions

What sell-side analysts currently cover shares of Profound Medical?

The following Wall Street sell-side analysts have issued reports on Profound Medical in the last twelve months: Alliance Global Partners, Lake Street Capital, Leede Jones Gab, Raymond James, and Zacks Investment Research.
View the latest analyst ratings for PROF.

What is the current price target for Profound Medical?

3 Wall Street analysts have set twelve-month price targets for Profound Medical in the last year. Their average twelve-month price target is $27.00, suggesting a possible upside of 138.5%. Lake Street Capital has the highest price target set, predicting PROF will reach $32.00 in the next twelve months. Alliance Global Partners has the lowest price target set, forecasting a price of $21.00 for Profound Medical in the next year.
View the latest price targets for PROF.

What is the current consensus analyst rating for Profound Medical?

Profound Medical currently has 2 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PROF will outperform the market and that investors should add to their positions of Profound Medical.
View the latest ratings for PROF.

What other companies compete with Profound Medical?

How do I contact Profound Medical's investor relations team?

Profound Medical's physical mailing address is 2400 SKYMARK AVENUE UNIT 6, MISSISSAUGA A6, L4W 5K5. The company's listed phone number is (647) 476-1350 and its investor relations email address is [email protected] The official website for Profound Medical is www.profoundmedical.com.